Heron Therapeutics
HRTX
#7836
Rank
C$0.37 B
Marketcap
$2.46
Share price
0.58%
Change (1 day)
-33.71%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.58

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.66. In 2022 the company made an earnings per share (EPS) of -$2.46 an increase over its 2021 EPS that were of -$3.20.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.58-35.82%
2022-$2.46-23.11%
2021-$3.20-10%
2020-$3.56-0%
2019-$3.561.21%
2018-$3.51-32.7%
2017-$5.22-19.34%
2016-$6.4754.76%
2015-$4.181.73%
2014-$4.11-16.23%
2013-$4.9191.67%
2012-$2.56-31.45%
2011-$3.73-27.06%
2010-$5.12-43.75%
2009-$9.10-57.33%
2008-$21.33-82.92%
2007-$124.8820.61%
2006-$103.54175.76%
2005-$37.55-21.43%
2004-$47.79100%
2003-$23.89-38.24%
2002-$38.69161.54%
2001-$14.79-106.46%
2000$228.842051.55%
1999$10.64839.73%
1998$1.13-105.48%
1997-$20.67-88.16%
1996-$174.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.85-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.20-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.32 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.23-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.35 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA